GLP-1 and Hair Loss: Causes and What to Do

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Hair loss reported with GLP-1 medications (semaglutide, tirzepatide) is typically telogen effluvium — a temporary shedding from rapid weight loss, not direct drug effect.
  • 5-7% of adults on GLP-1 medications report hair loss in clinical trials.
  • The mechanism is metabolic stress from rapid weight loss pushing hair follicles into resting phase prematurely.
  • Hair regrows over 6-12 months as weight stabilizes — typically full recovery.
  • slower weight loss, adequate protein, iron and vitamin D, biotin and other supplements.

Hair loss reported with GLP-1 medications (semaglutide, tirzepatide) is typically telogen effluvium — a temporary shedding from rapid weight loss rather than a direct drug effect. About 5 to 7% of adults on GLP-1 medications report hair loss in clinical trials. The mechanism is metabolic stress from rapid weight loss pushing hair follicles into the resting (telogen) phase prematurely. The same pattern occurs after bariatric surgery, severe illness, childbirth, and any rapid weight loss — it’s not specific to GLP-1 medications. Timing: hair loss typically begins 2-4 months after starting medication, lasts 3-6 months, and resolves over 6-12 months as weight stabilizes and nutritional status normalizes. Most adults achieve full recovery. Prevention strategies include slower weight loss pace, adequate protein intake (1.2-1.6 g/kg body weight daily), iron and vitamin D adequacy, and supplements (biotin, multivitamin with B vitamins, zinc, selenium).

Mechanism — Why Hair Falls Out

  • Hair grows in cycles: anagen (growth, 2-7 years), catagen (transition, 2-3 weeks), telogen (resting, 2-3 months).
  • Normally 90% of hair is in anagen, 10% in telogen at any time.
  • Telogen effluvium: stressor pushes 30%+ of hairs into telogen prematurely.
  • Hair sheds 2-3 months later as telogen-phase hairs fall out.
  • Triggers: severe illness, childbirth, surgery, rapid weight loss, severe stress, certain medications.
  • GLP-1 medications produce the trigger (rapid weight loss) rather than direct drug effect.

Prevention Strategies

Strategy Detail
Slower weight loss 1-2 lb/week vs 3-4 lb/week
Adequate protein 1.2-1.6 g/kg body weight daily
Iron adequacy Ferritin level >70 ng/mL; check with bloodwork
Vitamin D Level 40-60 ng/mL
Biotin 5,000 mcg daily (modest evidence; safe)
Multivitamin B vitamins, zinc, selenium for hair health
Avoid additional crash dieting GLP-1 already reduces appetite
Gentle hair care Avoid tight hairstyles, harsh chemicals

When to Seek Evaluation

  • Patchy bald spots (suggests alopecia areata).
  • Specific pattern (receding hairline, crown thinning) — androgenetic alopecia.
  • Hair loss persisting beyond 6 months.
  • Scalp redness, scaling, itching.
  • Other systemic symptoms (fatigue, weight gain, cold intolerance) — thyroid evaluation.
  • Significant nutritional deficiencies.
  • Adults with personal or family history of alopecia.

Diagnostic Workup

  • Ferritin (iron stores) — target above 70 ng/mL for hair growth.
  • Complete blood count.
  • Thyroid function (TSH).
  • Vitamin D level.
  • Vitamin B12.
  • Zinc level.
  • Hormone levels if androgenetic alopecia suspected (DHEA-S, testosterone).
  • Trichogram or hair pull test by dermatologist for diagnosis confirmation.

Treatments If Hair Loss Persistent

  • Telogen effluvium: typically self-resolves; ensure nutritional adequacy.
  • Minoxidil (Rogaine) topical: 2% or 5%; available OTC; works for various hair loss types.
  • Finasteride (Propecia): oral; for androgenetic alopecia in men; sexual side effects.
  • Spironolactone: for female pattern hair loss.
  • Platelet-rich plasma (PRP): injections to scalp; growing evidence.
  • Low-level laser therapy: at-home devices; modest evidence.
  • Hair transplantation: for established pattern hair loss.

The Bottom Line

Hair loss reported with GLP-1 medications (semaglutide, tirzepatide) is typically telogen effluvium — a temporary shedding from rapid weight loss rather than direct drug effect. About 5-7% of adults on GLP-1 medications experience this. The mechanism is metabolic stress from rapid weight loss pushing hair follicles into the resting phase prematurely; the same pattern occurs after bariatric surgery, severe illness, childbirth, and any rapid weight loss. Timing: hair loss typically begins 2-4 months after starting medication, lasts 3-6 months, and resolves over 6-12 months as weight stabilizes. Most adults achieve full recovery. Prevention strategies include slower weight loss pace (1-2 lb/week), adequate protein (1.2-1.6 g/kg body weight daily), iron adequacy (ferritin above 70 ng/mL), vitamin D adequacy (40-60 ng/mL), and supplements like biotin and multivitamin. If hair loss persists beyond 6 months or shows patterns suggesting other conditions (patchy bald spots, specific receding patterns, scalp changes, systemic symptoms), evaluation includes ferritin, thyroid function, vitamin D, and dermatologist visit. Most adults find reassurance that hair loss is temporary and regrows fully without treatment beyond addressing nutritional status. For adults bothered by appearance during the shedding phase, minoxidil topical is available OTC. See our broader GLP-1 medications guide for context.

Frequently Asked Questions

Does Ozempic cause hair loss directly?

Probably not directly. Hair loss reported with semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) is typically telogen effluvium — a temporary shedding from rapid weight loss rather than a direct drug effect. The mechanism is metabolic stress from rapid weight loss pushing hair follicles into the resting (telogen) phase prematurely. About 5-7% of adults on GLP-1 medications report hair loss in clinical trials. The same pattern occurs after bariatric surgery, severe illness, childbirth, and any rapid weight loss.

When does hair loss occur and how long does it last?

Telogen effluvium typically begins 2-4 months after the triggering event (in this case, rapid weight loss). Shedding lasts 3-6 months. Hair regrowth begins as new hairs enter the growth phase. Full regrowth typically takes 6-12 months. The hair loss is diffuse (all over scalp) rather than patchy, and total density may decrease 10-30% temporarily. Most adults achieve full recovery once weight stabilizes and nutritional status normalizes.

How can I prevent or reduce hair loss?

Several strategies. (1) Slower weight loss pace — 1-2 lb/week vs 3-4 lb/week reduces metabolic stress. (2) Adequate protein — 1.2-1.6 g/kg body weight daily; protein is essential for hair structure. (3) Iron — ferritin level above 70 ng/mL supports hair growth; many adults benefit from iron supplementation. (4) Vitamin D — adequate levels (40-60 ng/mL) support hair health. (5) Biotin (5,000 mcg) — common supplement; modest evidence but generally safe. (6) Multivitamin with B vitamins, zinc, selenium. (7) Avoid crash dieting on top of GLP-1 induced calorie reduction.

When should I see a doctor about hair loss?

Hair loss patterns warrant evaluation. (1) Patchy bald spots — possible alopecia areata or other condition. (2) Receding hairline or thinning at crown specifically — possible androgenetic alopecia. (3) Hair loss lasting beyond 6 months. (4) Scalp redness, scaling, itching. (5) Other symptoms (fatigue, weight gain, cold intolerance) — possible thyroid issue. Iron studies, ferritin, thyroid function, vitamin D level, and complete blood count are reasonable initial labs. Dermatologist evaluation for persistent or unusual patterns.

Sources

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine.
  3. American Academy of Dermatology. Telogen effluvium guidance.